Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rusthoven

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Cancer Investigation|January 1, 1990
5-Fluorouracil with folinic acid is not effective against metastatic adenocarcinoma of the lungW K Evans, R Wierzbicki, F A Shepherd, et al.
Journal of the National Cancer Institute|May 19, 1993
Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinomaJ J Rusthoven, E Eisenhauer, J Mazurka, et al.
Medical Care|April 1, 1998
Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed careB J O'Brien, R Goeree, A Gafni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomaNicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2023
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaNicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Molecular Cancer Therapeutics|December 14, 2002
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapyClet Niyikiza, Sharyn D Baker, David E Seitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesotheliomaGiorgio V Scagliotti, Dong-M Shin, Hedy L Kindler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, I C Quirt, N A Iscoe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials GroupJ Latreille, J Pater, D Johnston, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cancer Investigation|January 1, 1990
5-Fluorouracil with folinic acid is not effective against metastatic adenocarcinoma of the lungW K Evans, R Wierzbicki, F A Shepherd, et al.
Journal of the National Cancer Institute|May 19, 1993
Phase I clinical trial of recombinant human interleukin-3 combined with carboplatin in the treatment of patients with recurrent ovarian carcinomaJ J Rusthoven, E Eisenhauer, J Mazurka, et al.
Medical Care|April 1, 1998
Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed careB J O'Brien, R Goeree, A Gafni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesotheliomaNicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2023
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaNicholas J Vogelzang, James J Rusthoven, James Symanowski, et al.
Molecular Cancer Therapeutics|December 14, 2002
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapyClet Niyikiza, Sharyn D Baker, David E Seitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesotheliomaGiorgio V Scagliotti, Dong-M Shin, Hedy L Kindler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials GroupJ J Rusthoven, I C Quirt, N A Iscoe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials GroupJ Latreille, J Pater, D Johnston, et al.
Pageof 7